{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:08:18Z","timestamp":1776384498089,"version":"3.51.2"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Situated between two of the world\u2019s largest opium-producing regions, South Asia faces significant public health threats associated with drug trafficking and injecting drug use. People who inject drugs (PWID) in South Asia experience disproportionately high rates of bloodborne viruses (BBVs), including human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV). These high rates are driven by factors such as drug trafficking routes, socioeconomic marginalization, poor surveillance, and inadequate harm reduction services. Pakistan has the highest reported prevalence rates, with HIV and HCV rates exceeding 30% and 50%, respectively, while India, Bangladesh, and Afghanistan report localized epidemics in urban and border areas. Co-infections, particularly HIV\/HCV, further complicate clinical management and public health responses. Despite the implementation of needle-syringe programs and opioid substitution therapy in several countries, service coverage remains below recommended levels due to legal, financial, and structural barriers. Marginalized subgroups, including women and incarcerated individuals, remain underserved and often overlooked. In this review, we discuss the burden of these infections among PWID in South Asia, current control strategies, and the precarious future given the recent instability to the USAID, PEPFAR, WHO, and the Global Fund by the Trump administration.<\/jats:p>","DOI":"10.1186\/s12954-026-01433-x","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:16:35Z","timestamp":1773148595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An update on bloodborne viruses among people who inject drugs in South Asia"],"prefix":"10.1186","volume":"23","author":[{"given":"Md Ferdous","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Sharful Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad J. A.","family":"Shiddiky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mamun","family":"Huda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utpal K.","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeel","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"5","key":"1433_CR1","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e659\u201372. https:\/\/doi.org\/10.1016\/S2214-109X(23)00057-8.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"1433_CR2","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/s2214-109x(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207. https:\/\/doi.org\/10.1016\/s2214-109x(17)30375-3.","journal-title":"Lancet Glob Health"},{"key":"1433_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9060432","author":"R Rashti","year":"2020","unstructured":"Rashti R, Sharafi H, Alavian SM, Moradi Y, Mohamadi Bolbanabad A, Moradi G. Systematic review and meta-analysis of global prevalence of HBsAg and HIV and HCV antibodies among people who inject drugs and female sex workers. Pathogens Basel. 2020. https:\/\/doi.org\/10.3390\/pathogens9060432.","journal-title":"Pathogens Basel"},{"issue":"1","key":"1433_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13922-2","volume":"22","author":"LN Pachuau","year":"2022","unstructured":"Pachuau LN, Tannous C, Dhami MV, Agho KE. HIV among people who inject drugs in India: a systematic review. BMC Public Health. 2022;22(1):1529. https:\/\/doi.org\/10.1186\/s12889-022-13922-2.","journal-title":"BMC Public Health"},{"issue":"1","key":"1433_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0170-1","volume":"14","author":"SA Farooq","year":"2017","unstructured":"Farooq SA, Rasooly MH, Abidi SH, Modjarrad K, Ali S. Opium trade and the spread of HIV in the Golden Crescent. Harm Reduct J. 2017;14(1):47. https:\/\/doi.org\/10.1186\/s12954-017-0170-1.","journal-title":"Harm Reduct J"},{"key":"1433_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.573150","volume":"11","author":"S Naveed","year":"2020","unstructured":"Naveed S, Waqas A, Chaudhary AMD, Kumar S, Abbas N, Amin R, et al. Prevalence of common mental disorders in South Asia: a systematic review and meta-regression analysis. Front Psychiatry. 2020;11:573150. https:\/\/doi.org\/10.3389\/fpsyt.2020.573150.","journal-title":"Front Psychiatry"},{"issue":"4","key":"1433_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s2468-1253(24)00442-4","volume":"10","author":"A Artenie","year":"2025","unstructured":"Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H, et al. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol. 2025;10(4):315\u201331. https:\/\/doi.org\/10.1016\/s2468-1253(24)00442-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1433_CR8","unstructured":"UNODC. World Drug Report 2024 of the report; 2024. Available from: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html [accessed 01 April 2025]."},{"key":"1433_CR9","unstructured":"Harm Reduction International. The Global State of Harm Reduction 2024 of the report; 2024. Available from: https:\/\/hri.global\/flagship-research\/the-global-state-of-harm-reduction\/the-global-state-of-harm-reduction-2024\/ [accessed 15 April 2025]."},{"issue":"12","key":"1433_CR10","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208\u201320. https:\/\/doi.org\/10.1016\/S2214-109X(17)30373-X.","journal-title":"Lancet Glob Health"},{"key":"1433_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104145","volume":"119","author":"SK Zaccheo","year":"2023","unstructured":"Zaccheo SK, Marrone G, Pandey LR, Deuba K. The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal. Int J Drug Policy. 2023;119:104145. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104145.","journal-title":"Int J Drug Policy"},{"key":"1433_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100364","volume":"11","author":"HA Raza","year":"2024","unstructured":"Raza HA, Raja MHR, Khakwani MM, Jamil B. Pakistan\u2019s HIV high-risk populations: critical appraisal of failure to curtail spread beyond key populations. IJID Regions. 2024;11:100364. https:\/\/doi.org\/10.1016\/j.ijregi.2024.100364.","journal-title":"IJID Regions"},{"key":"1433_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100618","volume":"15","author":"MF Rahman","year":"2025","unstructured":"Rahman MF, Khan MSI, Huda MM, Mondal UK, Shiddiky MJA, Ross AG. The Global Fund\u2019s Bangladesh program. IJID Regions. 2025;15:100618. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100618.","journal-title":"IJID Regions"},{"key":"1433_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0079-5","volume":"12","author":"A Bergenstrom","year":"2015","unstructured":"Bergenstrom A, Achakzai B, Furqan S, ul Haq M, Khan R, Saba M. Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015. Harm Reduct J. 2015;12:43. https:\/\/doi.org\/10.1186\/s12954-015-0079-5.","journal-title":"Harm Reduct J"},{"key":"1433_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2019.03.009","volume":"83","author":"SI Khan","year":"2019","unstructured":"Khan SI, Reza MM, Crowe SM, Rahman M, Hellard M, Sarker MS, et al. People who inject drugs in Bangladesh\u2014the untold burden! Int J Infect Dis. 2019;83:109\u201315. https:\/\/doi.org\/10.1016\/j.ijid.2019.03.009.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1433_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-310","volume":"11","author":"NK Vaidya","year":"2011","unstructured":"Vaidya NK, Wu J. HIV epidemic in Far-Western Nepal: effect of seasonal labor migration to India. BMC Public Health. 2011;11(1):310. https:\/\/doi.org\/10.1186\/1471-2458-11-310.","journal-title":"BMC Public Health"},{"issue":"Supplement","key":"1433_CR17","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.4103\/ijph.IJPH_73_20","volume":"64","author":"S Biswas","year":"2020","unstructured":"Biswas S, Ghosh P, Chakraborty D, Kumar A, Aggarwal S, Saha MK. Variation in injecting drug use behavior across different North-eastern States in India. Indian J Public Health. 2020;64(Supplement):S71\u20135. https:\/\/doi.org\/10.4103\/ijph.IJPH_73_20.","journal-title":"Indian J Public Health"},{"key":"1433_CR18","unstructured":"Degenhardt L, Larance B, Mathers B, Azim T, Kamarulzaman A, Mattick R, et al. Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV Prepared on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use Sydney, University of New South Wales. 2008."},{"key":"1433_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-11-17","volume":"11","author":"SP Ojha","year":"2014","unstructured":"Ojha SP, Sigdel S, Meyer-Thompson HG, Oechsler H, Verthein U. 'South Asian cocktail\u2019\u2014the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour. Harm Reduct J. 2014;11:17. https:\/\/doi.org\/10.1186\/1477-7517-11-17.","journal-title":"Harm Reduct J"},{"key":"1433_CR20","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","volume":"26","author":"T Azim","year":"2015","unstructured":"Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. Int J Drug Policy. 2015;26:S16-21. https:\/\/doi.org\/10.1016\/j.drugpo.2014.09.003.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 4","key":"1433_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s2055-6640(20)31092-x","volume":"2","author":"R Pendse","year":"2016","unstructured":"Pendse R, Gupta S, Yu D, Sarkar S. HIV\/AIDS in the South-East Asia region: progress and challenges. J Virus Erad. 2016;2(Suppl 4):1\u20136. https:\/\/doi.org\/10.1016\/s2055-6640(20)31092-x.","journal-title":"J Virus Erad"},{"issue":"5","key":"1433_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/qad.0000000000000592","volume":"29","author":"GM Lucas","year":"2015","unstructured":"Lucas GM, Solomon SS, Srikrishnan AK, Agrawal A, Iqbal S, Laeyendecker O, et al. High HIV burden among people who inject drugs in 15 Indian cities. AIDS. 2015;29(5):619\u201328. https:\/\/doi.org\/10.1097\/qad.0000000000000592.","journal-title":"AIDS"},{"key":"1433_CR23","unstructured":"National ACO. Sankalak: Status of National AIDS & STD Response of the report. Sixth edition. 2024. Available from: [accessed 26 December 2025]."},{"key":"1433_CR24","unstructured":"ASP. Integrated Biological and Behavioural Survey (IBBS) among Key Populations at High Risk of HIV in Bangladesh, 2020 of the report; 2021. Available from: https:\/\/asp.gov.bd\/sites\/default\/files\/files\/asp.portal.gov.bd\/publications\/1f357413_2982_4047_aec6_9578327b51fa\/2022-10-17-03-25-bf484af619776bf838e3ebe79f65fda3.pdf [accessed 02 April 2025]."},{"key":"1433_CR25","unstructured":"Joint United Nations Programme on HIV AIDS. Afghanistan 2020 Country Report: AIDS Response Progress Report of the report; 2020. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/AFG_2020_countryreport.pdf [accessed 26 December 2025]."},{"issue":"1","key":"1433_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01183-2","volume":"22","author":"A Sabawoon","year":"2025","unstructured":"Sabawoon A, Naderi S, Sadaat SI, Rasheed A, Atarud A, Tavakoli F, et al. Recent HIV testing and self-reported HIV prevalence among men who inject drugs in Afghanistan: a nationwide survey in 2019\u20132020. Harm Reduct J. 2025;22(1):31. https:\/\/doi.org\/10.1186\/s12954-025-01183-2.","journal-title":"Harm Reduct J"},{"key":"1433_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.drugpo.2015.07.014","volume":"27","author":"CS Todd","year":"2016","unstructured":"Todd CS, Nasir A, Stanekzai MR, Fiekert K, Sipsma HL, Strathdee SA, et al. Impact of conflict and displacement on risk behaviours amongst people who inject drugs in Kabul, Afghanistan. Int J Drug Policy. 2016;27:173\u20137. https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.014.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1433_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3170-1","volume":"18","author":"KN Pokhrel","year":"2018","unstructured":"Pokhrel KN, Sharma VD, Pokhrel KG, Neupane SR, Mlunde LB, Poudel KC, et al. Investigating the impact of a community home-based care on mental health and anti-retroviral therapy adherence in people living with HIV in Nepal: a community intervention study. BMC Infect Dis. 2018;18(1):263. https:\/\/doi.org\/10.1186\/s12879-018-3170-1.","journal-title":"BMC Infect Dis"},{"key":"1433_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211062107","volume":"8","author":"J Damas","year":"2021","unstructured":"Damas J, Storm M, Pandey LR, Marrone G, Deuba K. Prevalence of HIV, hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study. Ther Adv Infect Dis. 2021;8:20499361211062107. https:\/\/doi.org\/10.1177\/20499361211062107.","journal-title":"Ther Adv Infect Dis"},{"key":"1433_CR30","unstructured":"National Centre for A, Control STD. National HIV Fact Sheet 2022 of the report; 2022. Available from: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/nepal-wad-factsheets-2022.pdf [accessed."},{"key":"1433_CR31","unstructured":"World Health Organization. HIV\/AIDS in the South-East Asia Region of the report; 2015. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/205305\/B4602.pdf?sequence=1 [accessed 12 April 2025]."},{"key":"1433_CR32","unstructured":"National Centre for A, Control STD. National Integrated Biological and Behavioral Surveillance (IBBS) Survey Among People Who Inject Drugs (PWID), Nepal\u20132020: Fact Sheet of the report; 2021. Available from: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/nepal-national-ibbs-pwid-fact-sheet-2021.pdf [accessed 26 December 2025]."},{"key":"1433_CR33","unstructured":"Ministry of National Health Services R, Coordination, National Aids Control Programme P. Integrated Biological and Behavioral Surveillance (IBBS) in Pakistan: Round 5, 2016\u20132017 of the report; 2017. Available from: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/ibbs-pakistan-round-5-2016-2017.pdf [accessed 26 December 2025]."},{"key":"#cr-split#-1433_CR34.1","unstructured":"National Std\/Aids Control Programme SL, Management Frontiers L. Integrated Biological and Behavioural Surveillance (IBBS) Survey among Key Populations at Higher Risk of HIV in Sri Lanka, 2017\/18: Report of the report"},{"key":"#cr-split#-1433_CR34.2","unstructured":"2018. Available from: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/sri-lanka-ibbs-survey-among-key-populations-higher-risk-hiv-2017-18.pdf [accessed 26 December 2025]."},{"key":"1433_CR35","unstructured":"World Health Organization: People who inject drugs. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/populations\/people-who-inject-drugs (2025). Accessed."},{"issue":"1","key":"1433_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12954-021-00505-4","volume":"18","author":"SJ Shayan","year":"2021","unstructured":"Shayan SJ, Nazari R, Kiwanuka F. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis. Harm Reduct J. 2021;18(1):59. https:\/\/doi.org\/10.1186\/s12954-021-00505-4.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1433_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/0971-5916.182626","volume":"143","author":"M Kermode","year":"2016","unstructured":"Kermode M, Nuken A, Medhi GK, Akoijam BS, Sharma HU, Mahanta J. High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India. Indian J Med Res. 2016;143(3):348\u201356. https:\/\/doi.org\/10.4103\/0971-5916.182626.","journal-title":"Indian J Med Res"},{"issue":"5&6","key":"1433_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4103\/ijmr.ijmr_1930_23","volume":"158","author":"L Shukla","year":"2023","unstructured":"Shukla L, Shivaprakash P, Kumar MS. HIV, hepatitis B & C in people who inject drugs in India: a systematic review of regional heterogeneity & overview of opioid substitution treatment. Indian J Med Res. 2023;158(5&6):522\u201334. https:\/\/doi.org\/10.4103\/ijmr.ijmr_1930_23.","journal-title":"Indian J Med Res"},{"key":"1433_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12954-015-0056-z","volume":"12","author":"CS Todd","year":"2015","unstructured":"Todd CS, Nasir A, Stanekzai MR, Fiekert K, Sipsma HL, Vlahov D, et al. Hepatitis c and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan. Harm Reduct J. 2015;12:22. https:\/\/doi.org\/10.1186\/s12954-015-0056-z.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1433_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252490","volume":"16","author":"R Didiya","year":"2021","unstructured":"Didiya R, Gyenwali D, Pokhrel TN, Devkota S, Rai AB, Shedain PR, et al. Community led testing among people who inject drugs: A community centered model to find new cases of HIV and hepatitis C in Nepal. PLoS ONE. 2021;16(5):e0252490. https:\/\/doi.org\/10.1371\/journal.pone.0252490.","journal-title":"PLoS ONE"},{"key":"1433_CR41","unstructured":"UNODC. Drug use characteristics. 2025."},{"issue":"3","key":"1433_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/dar.13595","volume":"42","author":"A Syangbo","year":"2023","unstructured":"Syangbo A, Hickman M, Colledge-Frisby S, Leung J, Grebely J, Larney S, et al. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: an ecological analysis. Drug Alcohol Rev. 2023;42(3):569\u201381. https:\/\/doi.org\/10.1111\/dar.13595.","journal-title":"Drug Alcohol Rev"},{"key":"1433_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugpo.2019.09.002","volume":"74","author":"M Rahman","year":"2019","unstructured":"Rahman M, Janjua NZ, Shafiq TKI, Chowdhury EI, Sarker MS, Khan SI, et al. Hepatitis c virus treatment in people who inject drugs (PWID) in Bangladesh. Int J Drug Policy. 2019;74:69\u201375. https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.002.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"1433_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797\u2013808. https:\/\/doi.org\/10.1016\/s1473-3099(15)00485-5.","journal-title":"Lancet Infect Dis"},{"key":"1433_CR45","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.17582\/journal.pjz\/20210509130526","volume":"54","author":"A Zahra","year":"2022","unstructured":"Zahra A, Saleem MA, Javed H, Khan MAU. Prevalence of HCV-HIV co-infection with intravenous drug users in Central Punjab, Pakistan. Pak J Zool. 2022;54:2185\u201392. https:\/\/doi.org\/10.17582\/journal.pjz\/20210509130526.","journal-title":"Pak J Zool"},{"issue":"1","key":"1433_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/s1473-3099(14)71045-x","volume":"15","author":"SS Solomon","year":"2015","unstructured":"Solomon SS, Mehta SH, Srikrishnan AK, Solomon S, McFall AM, Laeyendecker O, et al. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. Lancet Infect Dis. 2015;15(1):36\u201345. https:\/\/doi.org\/10.1016\/s1473-3099(14)71045-x.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1433_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264791","volume":"17","author":"LB Shrestha","year":"2022","unstructured":"Shrestha LB, Yadav GK, Pradhan S, Sharma A, Pandit T, Chhetry R, et al. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: a cross-sectional study from tertiary care hospital of eastern Nepal. PLoS ONE. 2022;17(3):e0264791. https:\/\/doi.org\/10.1371\/journal.pone.0264791.","journal-title":"PLoS ONE"},{"issue":"2","key":"1433_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","volume":"15","author":"DC Perlman","year":"2018","unstructured":"Perlman DC, Jordan AE. The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: structural-Level Causes and Interventions. Curr HIV\/AIDS Rep. 2018;15(2):96\u2013112. https:\/\/doi.org\/10.1007\/s11904-018-0390-3.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10072","key":"1433_CR49","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/s0140-6736(17)30003-x","volume":"389","author":"M Singer","year":"2017","unstructured":"Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941\u201350. https:\/\/doi.org\/10.1016\/s0140-6736(17)30003-x.","journal-title":"Lancet"},{"issue":"4","key":"1433_CR50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_963_23","volume":"66","author":"A Parmar","year":"2024","unstructured":"Parmar A, Chakraborty R, Balhara YPS. Current status of harm reduction in India: Are we doing enough? Indian J Psychiatry. 2024;66(4):388\u201391. https:\/\/doi.org\/10.4103\/indianjpsychiatry.indianjpsychiatry_963_23.","journal-title":"Indian J Psychiatry"},{"key":"1433_CR51","unstructured":"Harm Reduction International. Harm Reduction in Nepal: Information Note of the report; 2024. Available from: https:\/\/hri.global\/wp-content\/uploads\/2024\/05\/Nepal-HR-information-note-1.pdf [accessed 15 April 2025]."},{"issue":"1","key":"1433_CR52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12954-024-01084-w","volume":"21","author":"L Ganapathi","year":"2024","unstructured":"Ganapathi L, Srikrishnan AK, McFall AM, Gunaratne MP, Kumar MS, Lucas GM, et al. Expanding single-venue services to better engage young people who inject drugs: insights from India. Harm Reduct J. 2024;21(1):170. https:\/\/doi.org\/10.1186\/s12954-024-01084-w.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1433_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s44247-023-00055-8","volume":"2","author":"TKI Shafiq","year":"2024","unstructured":"Shafiq TKI, Shaikh K, Rahman F, Sarwar G, Hemel MMM, Khan TH, et al. A service provider\u2019s experience providing telehealth services during the COVID-19 pandemic in a community-based opioid substitution clinic in Bangladesh. BMC Digital Health. 2024;2(1):1. https:\/\/doi.org\/10.1186\/s44247-023-00055-8.","journal-title":"BMC Digital Health"},{"issue":"5","key":"1433_CR54","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","volume":"11","author":"S Colledge-Frisby","year":"2023","unstructured":"Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB, et al. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review. Lancet Glob Health. 2023;11(5):e673\u201383. https:\/\/doi.org\/10.1016\/S2214-109X(23)00058-X.","journal-title":"Lancet Glob Health"},{"key":"1433_CR55","unstructured":"National Aids\/Std Control MoHFW, Government of the People's Republic of Bangladesh,. Fifth National Strategic Plan for HIV and AIDS Response (2024\u20132028) in Bangladesh of the report; 2024. Available from: https:\/\/asp.portal.gov.bd\/sites\/default\/files\/files\/asp.portal.gov.bd\/page\/2d04f70c_c5e5_4d3d_9a13_e8cc7e5af9c9\/2025-02-13-10-46-758ae893460e66140f1fa7ded1794d27.pdf [accessed 05 May 2025]."},{"key":"1433_CR56","unstructured":"Harm Reduction International. The Death Penalty for Drug Offences: Global Overview 2023 of the report; 2023. Available from: https:\/\/hri.global\/death-penalty-2023 [accessed 10 April 2025]."},{"issue":"8","key":"1433_CR57","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1016\/s2352-3018(17)30073-5","volume":"4","author":"K DeBeck","year":"2017","unstructured":"DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357\u201374. https:\/\/doi.org\/10.1016\/s2352-3018(17)30073-5.","journal-title":"Lancet HIV"},{"key":"1433_CR58","unstructured":"Unaids. HIV and People Who Use Drugs\u2013Human Rights Fact Sheet Series 2024 of the report; 2024. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/02-hiv-human-rights-factsheet-people-who-use-drugs_en.pdf [accessed."},{"key":"1433_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103299","volume":"92","author":"SI Khan","year":"2021","unstructured":"Khan SI, Irfan SD, Khan MNM. \u201cI held on to the police\u2019s leg for mercy\u201d: Experiences of adversity, risk and harm among people who inject drugs during an anti-drug drive in Dhaka. Bangladesh Int J Drug Pol. 2021;92:103299. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103299.","journal-title":"Bangladesh Int J Drug Pol"},{"issue":"52","key":"1433_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09688080.2018.1543992","volume":"26","author":"OBK Dingake","year":"2018","unstructured":"Dingake OBK. The state of human rights in relation to key populations, HIV and sexual and reproductive health. Reprod Health Matters. 2018;26(52):46\u201350. https:\/\/doi.org\/10.1080\/09688080.2018.1543992.","journal-title":"Reprod Health Matters"},{"key":"1433_CR61","unstructured":"Davis C, Cook C, Gurung G. The Cost of Complacency: a Harm Reduction Funding Crisis of the report; 2024. Available from: https:\/\/hri.global\/flagship-research\/funding-for-harm-reduction\/cost-of-complacency\/ [accessed."},{"key":"1433_CR62","unstructured":"Joint United Nations Programme on HA. World AIDS Day Report 2025: Overcoming Disruption\u2013Transforming the AIDS Response of the report; 2025. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2025\/world-aids-day-report [accessed 2026\u201301\u201310]."},{"key":"1433_CR63","unstructured":"Institute for Health Metrics Evaluation. Development Assistance for Health Database 1990\u20132023. Seattle, WA: Institute for Health Metrics and Evaluation; 2024."},{"issue":"5","key":"1433_CR64","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/S2352-3018(25)00074-8","volume":"12","author":"D Brink","year":"2025","unstructured":"Brink D, Martin-Hughes R, Bowring AL, Wulan N, Burke K, Tidhar T, et al. Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study. Lancet HIV. 2025;12(5):e346\u201354. https:\/\/doi.org\/10.1016\/S2352-3018(25)00074-8.","journal-title":"Lancet HIV"},{"key":"1433_CR65","unstructured":"Kaiser Family F. The Trump Administration\u2019s Foreign Aid Review: Status of PEPFAR of the report; 2025. Available from: https:\/\/www.kff.org\/global-health-policy\/the-trump-administrations-foreign-aid-review-status-of-pepfar\/ [accessed January 10, 2026]."},{"key":"1433_CR66","unstructured":"The Global Fund to Fight Aids T, Malaria. Eighth Replenishment Pledging Conference: Outcomes and Pledges of the report; 2025. Available from: https:\/\/www.theglobalfund.org\/en\/replenishment\/ [accessed 2026-01-10]."},{"key":"1433_CR67","unstructured":"Harm Reduction I. The impact of a multi-country harm reduction advocacy grant in South-East Asia of the report; 2023. Available from: https:\/\/hri.global\/publications\/the-impact-of-a-multi-country-harm-reduction-advocacy-grant-in-south-east-asia [accessed 2025\/05\/13]."},{"key":"1433_CR68","unstructured":"World Health O. Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030 of the report; 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240053779 [accessed September 13, 2025]."},{"key":"1433_CR69","unstructured":"European ATG. Trump\u2019s USAID shutdown pushes 1.7 million people in Pakistan into crisis. European AIDS Treatment Group; 2025."},{"key":"1433_CR70","unstructured":"International Network of People who Use D. Community-Led Responses under Threat: findings from a Rapid Survey on Harm Reduction Funding of the report; 2024. Available from: https:\/\/www.inpud.net\/en\/community-led-responses-under-threat [accessed."},{"key":"1433_CR71","unstructured":"Kaiser Family Foundation. Global Health Funding in the FY 2025 President\u2019s Budget Request of the report; 2025. Available from: https:\/\/www.kff.org\/news-summary\/global-health-funding-in-the-fy-2025-presidents-budget-request\/ [accessed 15 May 2025]."},{"key":"1433_CR72","unstructured":"Unaids. Impact of US funding freeze on the global AIDS response\u2014weekly update. 2025."},{"key":"1433_CR73","unstructured":"Joint United Nations Programme on HA. Estimating the Potential Impact of HIV Response Disruptions of the report; 2025. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/2025-04\/JC3144_Estimates_Funding_cuts_impact_En.pdf [accessed."},{"key":"1433_CR74","unstructured":"International Network of People who Use Drugs. Community-led Responses under Threat: Findings from a Rapid Survey on Harm Reduction Funding of the report; 2024. Available from: https:\/\/www.inpud.net\/en\/community-led-responses-under-threat [accessed 20 April 2025]."},{"key":"1433_CR75","unstructured":"Tracker PI. Impact of the 90-day suspension of foreign aid on PEPFAR programs. 2025."},{"key":"1433_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r651","volume":"389","author":"L Taylor","year":"2025","unstructured":"Taylor L. WHO to cut budget by a fifth following Trump withdrawal. BMJ. 2025;389:r651. https:\/\/doi.org\/10.1136\/bmj.r651.","journal-title":"BMJ"},{"key":"1433_CR77","unstructured":"Kaiser Famil F. Breaking down the US global health budget by program area. 2025."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01433-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:25:22Z","timestamp":1776381922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01433-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01433-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this study as it is based solely on a review of publicly available, published literature and reports and does not involve primary data collection or human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}